Endologix (ELGX) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
General and administrative: 9.71M
Today's EPS Names:
CRMT, FOMI, FLES, More
Financial Fact:
General and administrative: 9.71M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Endologix (NASDAQ: ELGX) reported Q3 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $52.1 million versus the consensus estimate of $51.83 million.
GUIDANCE:
Endologix sees FY2016 revenue of $198-201 million, versus the consensus of $202 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- CareDx completes Naveris acquisition, adding cancer MRD testing
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
